Robert Kohn - Biopower Operations Chairman

BOPO Stock  USD 0.0001  0.00  0.00%   

Chairman

Mr. Robert D. Kohn, CPA, is President, Chief Executive Officer, Director of the Company. From February 23, 2017 to the present, Mr. Kohn was Managing Partner of The Asset Acquisition Group and from January 2018, Mr. Kohn was the CFO of WPP Energy GmbH. From August 2008 to July 2011, Mr. Kohn was a Managing Partner of Nelko Holdings LLC, which was formed for the purpose of evaluating business opportunities. Mr. Kohn from November 2009 to September 2010 was a consultant to Clenergen Corporationrationration, a reporting issuer and was also the Nonexecutive Vice Chairman until January 25, 2011. From July 2009 until September 2010, Mr. Kohn was also Interim Chief Financial Officer of Proteonomix, Inc., a public company involved in stem cell research. From March 2006 to July 2008, Mr. Kohn was the Interim CEO and CFO of Global Realty Development Corporationration and was hired to liquidate multiple Australian real estate development companies, which he accomplished. From 1999 2002 Mr. Kohn was the cofounder and CEO of Assetrade which today is GoIndustry with approximately 1, 200 employees in 21 countries. From 1999 to 2000 Mr. Kohn was the Chairman, CEO of entrade, com, a subsidiary of Entrade, a NYSE company and a member of their Board of Directors. From 1996 to 1999 Mr. Kohn was President of Entrade, a subsidiary of Exelon Corporationrationration, one of the largest electric utilities in the United States since 2019.
Age 73
Tenure 5 years
Professional MarksCPA
Phone786 923 0272
Webhttps://www.biopowercorp.com
Kohn has a B.B.A. in accounting from Temple University and is a C.P.A.

Biopower Operations Management Efficiency

The company has return on total asset (ROA) of (1.4082) % which means that it has lost $1.4082 on every $100 spent on assets. This is way below average. Biopower Operations' management efficiency ratios could be used to measure how well Biopower Operations manages its routine affairs as well as how well it operates its assets and liabilities.
Biopower Operations Corp currently holds 3.41 M in liabilities. Biopower Operations Corp has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Biopower Operations until it has trouble settling it off, either with new capital or with free cash flow. So, Biopower Operations' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biopower Operations Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biopower to invest in growth at high rates of return. When we think about Biopower Operations' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 12 records

CHAIRMAN Age

Susan DioBP PLC ADR
58
Eduardo FerreiraPetroleo Brasileiro Petrobras
67
Jon ReinhardsenEquinor ASA ADR
65
David SmithNational Fuel Gas
67
Emma MarcegagliaEni SpA ADR
53
Hector RojasEcopetrol SA ADR
57
Gustavo MarianiTransportadora de Gas
48
Patrick PouyanneTotalEnergies SE ADR
61
Luis FalloTransportadora de Gas
60
Helge LundBP PLC ADR
58
Jeroen VeerEquinor ASA ADR
73
Horacio MarinYPF Sociedad Anonima
61
BioPower Operations Corporation, through its subsidiaries, focuses on operating HyFi Platform. The company was incorporated in 2010 and is based in Aventura, Florida. Biopower Operations operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 1 people. Biopower Operations Corp [BOPO] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Biopower Operations Corp Leadership Team

Elected by the shareholders, the Biopower Operations' board of directors comprises two types of representatives: Biopower Operations inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biopower. The board's role is to monitor Biopower Operations' management team and ensure that shareholders' interests are well served. Biopower Operations' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biopower Operations' outside directors are responsible for providing unbiased perspectives on the board's policies.
Adam Benchaya, Chief Pres
Troy MacDonald, Chairman CEO
Marco BaezVelasquez, Chief Officer
Robert Kohn, Co-Founder, Chairman of The Board, CEO, CFO and Principal Accounting Officer

Biopower Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Biopower Operations a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Biopower Operations

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biopower Operations position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biopower Operations will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Biopower Operations could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biopower Operations when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biopower Operations - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biopower Operations Corp to buy it.
The correlation of Biopower Operations is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biopower Operations moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biopower Operations Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biopower Operations can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Biopower Pink Sheet

Biopower Operations financial ratios help investors to determine whether Biopower Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biopower with respect to the benefits of owning Biopower Operations security.